prednisone has been researched along with Limited Scleroderma in 3 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrich, V | 1 |
| Duvuru, S | 1 |
| Swanson, HJ | 1 |
| Roda-Safont, A | 1 |
| Simeón-Aznar, CP | 1 |
| Fonollosa-Plà, V | 1 |
| Segarra-Medrano, A | 1 |
| Vilardell-Tarrés, M | 1 |
| Mouthon, L | 1 |
| Berezné, A | 1 |
| Brauner, M | 1 |
| Kambouchner, M | 1 |
| Guillevin, L | 1 |
| Valeyre, D | 1 |
1 review available for prednisone and Limited Scleroderma
| Article | Year |
|---|---|
[Interstitial lung disease in systemic sclerosis].
Topics: Anti-Inflammatory Agents; Biopsy; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; | 2006 |
2 other studies available for prednisone and Limited Scleroderma
| Article | Year |
|---|---|
Limited scleroderma with pauci-immune glomerulonephritis in the presence of renal cell carcinoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2013 |
[Clinical features and prognosis of patients with scleroderma renal crisis].
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihyperten | 2011 |